BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI, and its approaches.
BioXcel Therapeutics Announces Last Patient...
Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected...
READ MORE